Developing a NanoFET Biosensor Based on MoS2 2D Material for Detecting Low Concentration Illness-Related Molecules
CSEF · 2016 Chemistry Honorable_mention Award
Overview
Objectives/Goals The objective of this study is to use advanced MoS2 2D material to chemically bind onto a silicon wafer in order to attempt to fabricate a biosensor that has the sensitivity strong enough to detect low concentration of biological molecules, such as early stage cancer. Methods/Materials - 6 inch diameter silicon wafers with SiO2 layer; - MoS2, Au tape - Photoresist SPR, developer MF-139, DI water, photomask, lithographic exposure tool; - Tumor necrosis factor alpha (TNF-alpha); - Optical microscopy, hot plate, exposure tool Results - MoS2 is a new and unique type of material to use when creating a sensitive transistor biosensor to detect low concentration of nanoscale molecules such as early stage forms of cancer. - Unique advantages of emerging 2-D materials for biosensing applications: Atomically thin structure => very sensitive to external stimulation => very high sensitivity. - The multiple sensors can be utilized to enable quantification of low-abundance biomarker molecules as well as the affinities and kinetics of antibody-mediated binding events. The sensors exhibited a TNF-alpha; detection limit as low as 60fM. - The real-time association/dissociation processes of the antibody-(TNF-alpha) pair were also quantified using multiple sensors. This detection capability can reduce the assay time, having the ability to detect the antigens several minutes to few hours. Conclusions/Discussion I was able to experimentally demonstrate through multiple trials that the MoS2-based transistor biosensors are capable of detecting illness-related biomarker molecules with detection limit as low as 60 fM. MoS2 proved to be an attractive choice because of its flexibility and high sensitivity. This is very useful and sensitive to the early detection of illness-related biomarker molecules, such as cancerous cells, and can provide a much more efficient and effective process of detecting early stages of cancer development.
Summary statement
I successfully demonstrated through multiple trials that the MoS2-based transistor biosensors are capable of detecting low concentrations of illness-related biomarker molecules, such as early stages of cancerous cells.
Help received
University of Michigan
Awards (1)
- Honorable Mention
Competition history
- CSEF 2016
Resources
Related projects
CSEF · 2017
Developing a Novel Flexible MoS2 Biosensor to Detect Lower-Concentrated Biomolecules at the Femtomolar Level
ISEF · 2017
Developing a Novel Flexible MoS2 Biosensor to Detect Lower-Concentrated Area of Biological Molecules at the Femtomolar Level
ISEF · 2018
Fabricating a Novel Ultrasensitive Flexible Biosensor with Patterned 10 nm Single Antibody Size Periodic Line Channel Created by Directed Molecular Self-Assembly to Achieve Extremely High Accuracy in the Earlier Detection of Cancer
CSEF · 2017
Characterization of 2D Molybdenum Disulfide Crystal Growth for Nano-Optics and the Extension of Moore's Law
ISEF · 2021
Functionalized Biosensor for Tissue Plasminogen Activator (tPA) Detection
ISEF · 2015
Design and Synthesis of a Novel Biosensor Platform for Health Diagnostics
CSEF · 2017
Application of Nanostructured Porous Silicon as an Electrical Biosensor for Alzheimer's Screening
ISEF · 2021
Investigation and Design of Two-Dimensional Nanomaterial Biosensors for Breath-Based COVID-19 Detection Using Density Functional Theory
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects